Trial Profile
Finite duration treatment in pre-cirrhotic chronic hepatitis B virus (HBV) infection: Phase IV study of Lamivudine priming of Pegasys treatment in HBeAg positive patients
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 22 Jun 2011
Price :
$35
*
At a glance
- Drugs Lamivudine (Primary) ; Peginterferon alfa-2a (Primary)
- Indications Hepatitis B
- Focus Therapeutic Use
- 22 Jun 2011 New trial record